Literature DB >> 1825048

Standards for evaluating results of interventional therapy for peripheral vascular disease.

R B Rutherford1.   

Abstract

Uniform standards for evaluating and reporting the results of therapeutic interventions for peripheral vascular disease are clearly needed. They are already established for vascular surgery, as represented by several reports by SVS/ISCVS committees, but they are not always followed by vascular surgeons and have been largely ignored by other vascular interventionists. In this article, the major problematic reporting practices are discussed and illustrated, and 14 recommendations are advanced to deal with them. They are intended to provide precise definitions, objective criteria of success or failure, standardized severity gradation schemes for peripheral vascular disease and its risk factors, and proper procedures for reporting the outcome of all forms of therapeutic intervention. Until these or some other agreed upon reporting standards are accepted and followed, the literature on peripheral vascular disease and its management will continue to be a source of confusion rather than enlightenment.

Entities:  

Mesh:

Year:  1991        PMID: 1825048

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  3 in total

1.  Intraarterial pressure gradients after randomized angioplasty or stenting of iliac artery lesions. Dutch Iliac Stent Trial Study Group.

Authors:  E Tetteroo; C Haaring; Y van der Graaf; J P van Schaik; A D van Engelen; W P Mali
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Nov-Dec       Impact factor: 2.740

2.  Infrainguinal directional atherectomy: long-term follow-up and comparison with percutaneous transluminal angioplasty.

Authors:  P M Wildenhain; M H Wholey; C R Jarmolowski; K L Hill
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Nov-Dec       Impact factor: 2.740

3.  An aggressive policy of bilateral saphenous vein harvest for infragenicular revascularisation in the era of multidrug resistant bacteria.

Authors:  G J Murphy; D Kipgen; M J S Dennis; R D Sayers
Journal:  Postgrad Med J       Date:  2002-06       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.